Coronavirus information

Visitor restrictions, information for patients and more.

View coronavirus information

FOI 0748 2020/21 Drug Treatments Regardless Of Diagnosis

Home > FOI Requests > Patient Data > FOI 0748 2020/21 Drug Treatments Regardless Of Diagnosis

July 17, 2020

Last updated: July 17, 2020

Freedom of Information Request: 0748 2020/21

Within your health trust how many patients are currently (within the past 3 months) being treated with the following regardless of patient diagnosis

Abemaciclib + aromatase inhibitor – 1

Abemaciclib + Fulvestrant – 51

Alpelisib + Fulvestrant – 0

Atezolizumab – 7

Avelumab – 0

Bevacizumab – 14

Eribulin – 13

Everolimus + Exemestane – 13

Fulvestrant as a single agent – 29

Gemcitabine + paclitaxel – 0

Herceptin IV – 0

Herceptin SC – 26

Lapatinib – 0

Neratinib – 4

Nivolumab – 10

Olaparib – 6

Palbociclib + aromatase inhibitor – 3

Pembrolizumab  – 20

Pertuzumab + trastuzumab + docetaxel – 74

Ribociclib + aromatase inhibitor – 0

Ribociclib + Fulvestrant – 31

Talazoparib – 0

Transtuzumab biosimilar IV – 13

Transtuzumab biosimilar SC – 20

Trastuzumab emtansine – 59

 

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.